GlassScriptPhysician profile
Amod P Tendulkar
NPI 1457511628
$7,633.39
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,206 · 2020: $757 · 2021: $670.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,319.05 | 2019-2020 | |
| Medtronic Vascular, INC. | $2,085.20 | 2019-2020 | |
| Abbott Laboratories | $1,749.88 | 2019-2021 | |
| Medtronic, INC. | $437.17 | 2021 | |
| Edwards Lifesciences Corporation | $323.13 | 2019-2021 | |
| Silk Road Medical, INC. | $266.01 | 2019 | |
| Pulmonx Corporation | $133.55 | 2019-2020 | |
| Boston Scientific Corporation | $92.59 | 2019-2020 | |
| Abiomed | $83.23 | 2021 | |
| Janssen Pharmaceuticals, INC | $82.17 | 2019 | |
| Davol INC. | $44.96 | 2020 | |
| Elutia, INC. | $16.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amod Tendulkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.